C OMPUTER MODELING is having a profound impact on biology, ranging from algorithms that help assemble DNA sequences 1 to methods that compare the genomes of whole organisms. 2 Modeling is being used to describe phenomena as diverse as proteinprotein interactions 3 or the flux through metabolic pathways. 4 Simulations are even being used to describe and predict the response of neurons to environmental stimuli. 5 Computational analysis is also starting to have an impact on high-throughput screening (HTS), with modeling being used to help improve or correct systematic errors in screening data. 6 Chemoinformatic data-mining methods are being applied to help describe HTS data, and sophisticated methods have even been reported allowing prediction of compound activity. 7 However, neither of these applications seems to have gained as widespread acceptance and regular use as the methods for data correction, normalization, and analysis of microarray data. Why is this? One possible answer is that microarray data sets were made publicly available during the development of this field. 8 This, in turn, allowed data sets to be analyzed and reanalyzed to identify improved methods of data analysis. 9,10 As a result, different data analysis methods can be directly compared.
ranging from algorithms that help assemble DNA sequences 1 to methods that compare the genomes of whole organisms. 2 Modeling is being used to describe phenomena as diverse as proteinprotein interactions 3 or the flux through metabolic pathways. 4 Simulations are even being used to describe and predict the response of neurons to environmental stimuli. 5 Computational analysis is also starting to have an impact on high-throughput screening (HTS), with modeling being used to help improve or correct systematic errors in screening data. 6 Chemoinformatic data-mining methods are being applied to help describe HTS data, and sophisticated methods have even been reported allowing prediction of compound activity. 7 However, neither of these applications seems to have gained as widespread acceptance and regular use as the methods for data correction, normalization, and analysis of microarray data. Why is this? One possible answer is that microarray data sets were made publicly available during the development of this field. 8 This, in turn, allowed data sets to be analyzed and reanalyzed to identify improved methods of data analysis. 9,10 As a result, different data analysis methods can be directly compared.
Unfortunately, this has not been true with HTS data sets, probably due to their predominantly proprietary nature. This has forced chemoinformatics groups to generate their own "HTS" data sets using compounds of known structure and activity (say, from the MDDR or Merck index) and assume that a compound with one activity does not show activity in other possible assays. Or, alternatively, researchers have used the National Cancer Institute (NCI) data set 11 as a surrogate HTS screening set. This information, though, does not reflect most HTS screening results because of the relatively limited diversity of the compound set, the appearance of many compounds that are not usually represented in pharmaceutical compound libraries (e.g., metal compounds or natural products), and the fact that IC 50 data are reported that are much less noisy than typical HTS results.
Therefore, the aim of the exercise described herein was to try and open up the field of HTS data analysis to chemoinformatic analysis by providing a "real" HTS data set, collected under actual screening conditions. Training and test sets were chosen and tested under real-world constraints of practicality, and most important, the answers were not known before starting the project.
This edition of the Journal of Biomolecular Screening presents the results of this experiment. First, the judges present an overview of the problem, the ways used to address the challenge, and lessons learned from this project. Also discussed are ways in which the competition might be improved, if conducted again. Second, the screeners (the vital keystone of this whole endeavor) describe the assay and the pertinent screening characteristics. Third, what follows is a series of articles from invited participants who were successful in the analysis of the data sets.
It is hoped that this will prove useful in 3 ways:
1. highlight the work done in the field to a larger audience, helping to bring screeners and computational modelers together in a common forum; 2. highlight the successful methods that were applied to the problem presented; and 3. expose the areas where improvements could be made in the current methods for modeling and predicting HTS data.
In conclusion, I would like to thank all those who helped make this possible: the screeners at the McMaster HTS Lab who were willing to freely share their data (in the best traditions of academic science), the competitors who took the time and effort to present their different data-mining strategies and tools, the judges who have worked to evaluate the many entries, and finally the Journal of Biomolecular Screening for allowing the results to be presented here.
